Home    Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies.

Ito M*, Ibi T, Sahashi K, Ichihara M, Ito M, Ohno K.

*Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.


論文:http://www.ncbi.nlm.nih.gov/pubmed/22146674

関連記事

返信する